CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Recruiting · St Louis, Missouri
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers. The investigators will roll out these resources in stages across clinics. The study will measure how well the program helps clinicians prescribe SMART therapy and whether it reduces asthma exacerbations in patients.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •People age 12 or older who have been diagnosed with asthma.
- •Patients who have had at least 2 asthma flare-ups in the past year that needed systemic steroid treatment (by mouth or injection) and/or meet the inhaler medicine pattern described.
- •Clinics in the St. Louis Integrated Health Center Network for Community Academic Partnerships that have enough clinicians managing adult asthma.
- •Clinicians/staff with a current state license (doctor, assistant physician, nurse practitioner, or physician assistant) who regularly care for adults with asthma.
- •Clinicians/staff who can take part for the whole study and provide data on prescribing and asthma outcomes.
🚫 You may not be able to join if…
- •People under 12 years old.
- •People without an asthma diagnosis coded as ICD-10-CM J45**.
- •Patients who do not have at least 2 asthma exacerbations in the last year needing systemic corticosteroids and/or who do not have the specified inhaler regimen (medium+ ICS maintenance or low+ ICS-LABA maintenance with a reliever SABA).
- •Clinics that are not in the St. Louis Integrated Health Center Network for Community Academic Partnerships.
- •Clinicians/staff who do not have an eligible current state license or who cannot use the SMART implementation bundle during the study.
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 12–any age
- ✓Have Asthma
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
Yes. This treatment has already been through earlier human studies for safety before reaching this stage.
What you need to know before you apply
What is this study testing?+
Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers.
Is it safe? Who makes sure of that?+
This is a study of an already-approved treatment (Phase 4). Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
Do I have to stop taking my current medications?+
It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.
Does it cost anything? Will I be paid?+
Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Source: ClinicalTrials.gov · NCT07241117 · Locations: Missouri